Search research articles
Contact Us
Filters
Showing results (1-10 of 62) with videos related to
Page
of 7
Sort By:
The Oncologist
|
June 1, 2017
Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field
Clinton Yam, Sendurai A Mani, Stacy L Moulder
Journal of Biomedical Science
|
October 26, 2022
Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors
Yu-Yi Chu, Clinton Yam, Hirohito Yamaguchi, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
September 21, 2018
Innovative Strategies: Targeting Subtypes in Metastatic Breast Cancer
Mark D Pegram, Yu Zong, Clinton Yam, et al.
Scientific Reports
|
November 26, 2025
Predicting the response of triple negative breast cancer to neoadjuvant systemic therapy via biology-based modeling and habitat analysis
Casey E Stowers, Chengyue Wu, Clinton Yam, et al.
The Journal of Surgical Research
|
September 22, 2009
Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer
Clinton Yam, Ming Zhao, Katsuhiro Hayashi, et al.
Cancer Medicine
|
February 7, 2022
Clinical outcomes and Oncotype DX Breast Recurrence Score® in early-stage BRCA-associated hormone receptor-positive breast cancer
Rachel M Layman, Heather Lin, Angelica M Gutierrez Barrera, et al.
Archives of Pathology & Laboratory Medicine
|
April 19, 2023
TRPS1 and GATA3 Expression in Invasive Breast Carcinoma With Apocrine Differentiation
Jing Wang, Yan Peng, Hongxia Sun, et al.
Breast Cancer Research and Treatment
|
June 21, 2024
Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States
Kevin Kalinsky, Laura Spring, Clinton Yam, et al.
Annals of Surgical Oncology
|
November 16, 2023
Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer
Ashley A Woodfin, Clinton Yam, Mediget Teshome, et al.
NPJ Digital Medicine
|
April 8, 2025
MRI-based digital twins to improve treatment response of breast cancer by optimizing neoadjuvant chemotherapy regimens
Chengyue Wu, Ernesto A B F Lima, Casey E Stowers, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 62) with videos related to
Sort By:
Page
of 7
The Oncologist
|
June 1, 2017
Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field
Clinton Yam, Sendurai A Mani, Stacy L Moulder
Journal of Biomedical Science
|
October 26, 2022
Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors
Yu-Yi Chu, Clinton Yam, Hirohito Yamaguchi, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
September 21, 2018
Innovative Strategies: Targeting Subtypes in Metastatic Breast Cancer
Mark D Pegram, Yu Zong, Clinton Yam, et al.
Scientific Reports
|
November 26, 2025
Predicting the response of triple negative breast cancer to neoadjuvant systemic therapy via biology-based modeling and habitat analysis
Casey E Stowers, Chengyue Wu, Clinton Yam, et al.
The Journal of Surgical Research
|
September 22, 2009
Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer
Clinton Yam, Ming Zhao, Katsuhiro Hayashi, et al.
Cancer Medicine
|
February 7, 2022
Clinical outcomes and Oncotype DX Breast Recurrence Score® in early-stage BRCA-associated hormone receptor-positive breast cancer
Rachel M Layman, Heather Lin, Angelica M Gutierrez Barrera, et al.
Archives of Pathology & Laboratory Medicine
|
April 19, 2023
TRPS1 and GATA3 Expression in Invasive Breast Carcinoma With Apocrine Differentiation
Jing Wang, Yan Peng, Hongxia Sun, et al.
Breast Cancer Research and Treatment
|
June 21, 2024
Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States
Kevin Kalinsky, Laura Spring, Clinton Yam, et al.
Annals of Surgical Oncology
|
November 16, 2023
Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer
Ashley A Woodfin, Clinton Yam, Mediget Teshome, et al.
NPJ Digital Medicine
|
April 8, 2025
MRI-based digital twins to improve treatment response of breast cancer by optimizing neoadjuvant chemotherapy regimens
Chengyue Wu, Ernesto A B F Lima, Casey E Stowers, et al.
Page
of 7